Type One Diabetes Completed Phase 4 Trials for Insulin aspart (DB01306)

Back to Type One Diabetes

Also known as: Diabetes Mellitus, Juvenile-Onset / T1DM - Type 1 Diabetes Mellitus / Diabetes Type I / Type I Diabetes / Type1 Diabetes / Diabetes Type One / Diabete Type 1 / Type One Diabetes Mellitus / Diabetics Mellitus Type 1 / Type 1 Diabetes / Type 1 Diabetes Mellitus (T1DM) / Insulin-Dependent Diabetes Mellitus 1 / Type1diabetes / Diabetes Mellitus Type I / Type1 Diabetes Mellitus / Type 1 Diabetes (T1D) / Diabetes Mellitus Type 1 / Juvenile Onset Diabetes Mellitus / Diabetes Type 1 / Type 1 Insulin-Dependent Diabetes Mellitus / Type I Diabetes Mellitus / Diabetes Mellitus, Sudden-Onset / Type-1 Diabetes Mellitus / Insulin Dependent Diabetes Mellitus 1 / Type 1 Diabetes Mellitus / Juvenile-Onset Diabetes / Diabetes Mellitus, Insulin-Dependent, 1 / Diabetes mellitus type 1 (disorder) / Diabetes mellitus: [juvenile] or [insulin dependent] / Juvenile diabetes / Insulin dependent diabetic / IDDM / Diabetes mellitus insulin-dependent / Insulin-dependent diabetes mellitus / Diabetes mellitus juvenile onset / Immune-mediated diabetes / Insulin dependent diabetes mellitus / Insulin dependent diabetes mel / IDDM - Insulin-dependent diabetes mellitus / Diabetes mellitus - juvenile / Ketosis-prone diabetes mellitus (disorder) / Ketosis-prone diabetes mellitus

Indication	Status	Phase
DBCOND0076728 (Type One Diabetes)	Completed	4

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00346996	Insulin Analogues and Severe Hypoglycaemia	Treatment	Insulin aspart (DB01306) Insulin detemir (DB01307) Insulin human (DB00030)
NCT04157738	A Study of Rapid-Acting Mealtime Insulin in Children and Adolescents With Newly Diagnosed Type 1 Diabetes Mellitus	Treatment	Glulisine (DB31448) Insulin aspart (DB01306) Insulin glargine (DB00047) Insulin human (DB00030)
NCT03987191	Insulin Pump to Multiple Daily Injection Transition Clinical Trial	Treatment	Insulin aspart (DB01306) Insulin degludec (DB09564)
NCT04053712	Dual-hormone Closed-loop Glucose Control in Type 1 Diabetes	Treatment	Glucagon (DB00040) Insulin aspart (DB01306)
NCT02276859	Normal Versus Dual Wave Insulin Bolus for High-protein Food	Treatment	Insulin aspart (DB01306) Insulin glulisine (DB01309) Insulin lispro (DB00046)
NCT01269047	Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia	Treatment	Exenatide (DB01276) Insulin aspart (DB01306) Insulin detemir (DB01307) Insulin glargine (DB00047) Insulin human (DB00030) Insulin lispro (DB00046) Pramlintide (DB01278)
NCT01269034	New Onset Type 1 Diabetes: Role of Exenatide	Treatment	Exenatide (DB01276) Insulin aspart (DB01306) Insulin detemir (DB01307) Insulin glargine (DB00047) Insulin human (DB00030) Insulin lispro (DB00046)
NCT04409587	Basal Insulin Glycemic ControL With DEglugec vs Aspart Via Pump	Treatment	Degludec (DB22807) Insulin aspart (DB01306) Insulin degludec (DB09564)
NCT04019821	Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index Meal	Treatment	Insulin aspart (DB01306) Insulin glulisine (DB01309) Insulin lispro (DB00046)
NCT03554486	Evaluation of Fiasp® (Fast Acting Insulin Aspart) in 670G Hybrid Closed-Loop Therapy	Treatment	Insulin aspart (DB01306)
NCT00597233	Human Insulin NPH and Insulin Aspart in Type 1 Diabetes	Treatment	Insulin aspart (DB01306) Insulin human (DB00030)
NCT00571935	Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 Diabetes	Treatment	Insulin aspart (DB01306) Insulin human (DB00030)
NCT00365170	Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes	Treatment	Insulin aspart (DB01306) Insulin human (DB00030)
NCT01526733	Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase	Treatment	Hyaluronidase (human recombinant) (DB06205) Insulin aspart (DB01306) Insulin lispro (DB00046)
NCT03328845	Impact on the Oxidative Stress of the Different Analogues of Insulin in People With Type 1 Diabetes. (Ineox Study)	Treatment	Glulisine (DB31448) Insulin aspart (DB01306) Insulin degludec (DB09564) Insulin glargine (DB00047) Insulin glulisine (DB01309) Insulin human (DB00030) Insulin lispro (DB00046)
NCT00913497	The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children	Treatment	Insulin aspart (DB01306) Insulin glulisine (DB01309)
NCT03659799	Comparison of FiAsp and Aspart During Postprandial Exercise in Adults With Type 1 Diabetes	Treatment	Insulin aspart (DB01306) Insulin human (DB00030)
NCT00497536	Pharmacokinetics of IAsp Following CSII in Patients With T1DM	Treatment	Insulin aspart (DB01306)
NCT00593255	Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes	Treatment	Insulin aspart (DB01306) Insulin human (DB00030)
NCT02192450	Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia	Treatment	Degludec (DB22807) Insulin aspart (DB01306) Insulin degludec (DB09564) Insulin glargine (DB00047)
NCT00607087	Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus	Treatment	Insulin aspart (DB01306) Insulin glulisine (DB01309) Insulin lispro (DB00046)
NCT01467141	Safety and Efficacy of Insulin Aspart in Children With Type 1 Diabetes	Treatment	Insulin aspart (DB01306) Insulin human (DB00030)
NCT01678235	Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus	Treatment	Insulin aspart (DB01306) Insulin glulisine (DB01309)
NCT00542620	Comparison of Insulin Detemir and Insulin Aspart in 2 Separate Injections Twice Daily to Extemporaneous Mixing Injection Regimen Twice Daily - The Paediatric Mixing Trial	Treatment	Insulin aspart (DB01306) Insulin detemir (DB01307)
NCT00461331	Comparison of Insulins Aspart and Lispro in Insulin Pumps	Treatment	Insulin aspart (DB01306) Insulin human (DB00030) Insulin lispro (DB00046)
NCT00117780	Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes	Treatment	Insulin aspart (DB01306) Insulin detemir (DB01307)
NCT00442767	Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus	Treatment	Insulin aspart (DB01306) Insulin human (DB00030) Pramlintide (DB01278)
NCT00095446	NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes	Diagnostic	Insulin aspart (DB01306)
NCT01848990	CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)	Treatment	Glulisine (DB31448) Hyaluronidase (human recombinant) (DB06205) Insulin aspart (DB01306) Insulin glulisine (DB01309) Insulin lispro (DB00046)
NCT04124302	The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.	Treatment	Insulin aspart (DB01306) Insulin glulisine (DB01309) Insulin lispro (DB00046)